Form 485BPOS FIDELITY CONCORD STREET streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
New data on tirzepatide for weight loss and potential type 2 diabetes remission as well as an update on use of dapagliflozin for heart failure will be presented at the first in-person EASD meeting for 3 years.
The "twincretin" tirzepatide scored another pivotal-trial win in published results from the SURPASS-4 trial, which compared the investigational agent to insulin glargine for treatment of type 2 diabetes.
Four diabetes and obesity experts make the case for targeting weight loss of at least 15% as a front-line treatment goal for many patients with type 2 diabetes.
EASD: Precision in Diabetes Management and Impact of COVID-19 medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.